Table of Contents
Rhythm Pharmaceuticals, Inc. RYTM was a big mover last session, as the company saw its shares rise more than 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company—as the stock is down 16.5% in the past one-month time frame.
The company has seen no estimate revision in the past month, while the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Rhythm Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Rhythm Pharmaceuticals, Inc. Price
Rhythm Pharmaceuticals, Inc. price | Rhythm Pharmaceuticals, Inc. Quote
A better-ranked stock in the Medical – Biomedical and Genetics industry is Emergent BioSolutions Inc. EBS, which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Just Released: Zacks’ 7 Best Stocks for Today
Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.3% per year.
These 7 were selected because of their superior potential for immediate breakout.
See these time-sensitive tickers now >>
Click to get this free report
Emergent Biosolutions Inc. (EBS): Free Stock Analysis Report
Rhythm Pharmaceuticals, Inc. (RYTM): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.